Sigma drops as Boots pursuit puts focus on funding
Sigma Healthcare Ltd shares dropped Wednesday after the Chemist Warehouse owner said it has started early talks about a possible Boots Group sale. What started as a slow UK expansion is now raising bigger doubts around deal size, funding and execution. Reuters said Sigma lost more than 5% to A$2.76, the lowest close since April 28. Australia’s main index closed up 0.7%. Sigma’s interest in the UK wasn’t news for investors—they knew that part. The shift now is about scale. Sigma’s brief ASX update said it looks at deals that could boost shareholder value and has started early talks on the Boots sale. But Sigma also cautioned a deal may not happen.